Clin2
NCT05880056Possibly a fitRecruiting

Dissolving bisoprolol film for newly diagnosed high blood pressure

Essential Hypertension

Part of Heart & circulation clinical trials.

This trial tests a dissolving form of bisoprolol (a blood-pressure medicine) in people in Egypt with newly diagnosed mild to moderate high blood pressure. It aims to see how well this specific dose form controls blood pressure and fits everyday use.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
406 people
Ages
21 years to 65 years
Study type
Interventional

Who can take part

  • You can sign a consent form and join the study
  • You are 21 to 64 years old
  • Your BMI is at least 18.5 but under 30
  • Your blood pressure is newly diagnosed and in grade 1 or grade 2 range (not a crisis)
  • Your resting heart rate is 80 or higher

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07373613Not yet recruiting· Phase 2
Testing new drugs for high blood pressure

This trial tests five new medications to see how well they lower blood pressure in people with essential hypertension (high blood pressure with no known cause). Participants will temporarily stop their current blood pressure medicine during the study.

Soeul
NCT07421375Not yet recruiting· Phase 1
Study of BR1015 drug levels and safety in healthy adults

This trial tests a new drug, BR1015, to see how it moves through the body and if it is safe. It is for healthy adults who are willing to fast before taking the medicine.

NCT06938516Recruiting
Study of Nebilet for high blood pressure

This study is for people with high blood pressure who are taking or about to start the medication Nebilet. It will track how well Nebilet controls blood pressure in real-world settings, including people with other heart conditions.

Semarang, Central Java
NCT07352969Not yet recruiting· Phase 2
Testing a new hypertension drug in mild to moderate patients

This trial tests a new medicine called IBI3016 for people with mild to moderate high blood pressure. It aims to find the right dose to safely lower blood pressure without other blood pressure medications.

Beijing, Beijing Municipality
NCT07708441Not yet recruiting· Phase 2/Phase 3
Testing a new pill for hard-to-treat high blood pressure

This trial tests a new medication (HRS-1780) for people whose high blood pressure is not well controlled, even with current treatments. It may help lower blood pressure effectively.

Chongqing, Chongqing Municipality
NCT07686120Not yet recruiting· Phase 3
Study of baxdrostat for Chinese adults with hard-to-treat high blood pressure

This trial is testing if a new medication called baxdrostat can help lower blood pressure in people who are already taking two or more blood pressure medications but still have uncontrolled high blood pressure. It is for Chinese adults only and will compare the study drug to a placebo (inactive pill).

Hear when a new Essential Hypertension trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.